Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2012
Date:5/8/2012

$20,014Licensing and royalty revenue1,4171,133Total revenue23,23521,147Expenses:Research and development38,71434,245General and administrative2,9763,010Total operating expenses41,69037,255Loss from operations(18,455)(16,108)Other income (expense):Equity in net loss of Regulus Therapeutics Inc.(976)(856)Investment income600705Interest expense(5,179)(3,415)Gain (loss) on investments, net17(318)Loss before income tax expense$(23,993)$(19,992)Income tax expense(2)(2)Net loss$(23,995)$(19,994)Basic and diluted net loss$(0.24)$(0.20)Shares used in computing basic and diluted net loss per share100,15799,569Isis Pharmaceuticals, Inc.Reconciliation of GAAP to Pro Forma Basis:  Condensed Consolidated Operating Expenses and Loss From Operations (In Thousands)Three months ended,

March 31,20122011(unaudited)As reported operating expenses according to GAAP$41,690$37,255Excluding compensation expense related to equity awards(2,267)(2,732)Pro forma operating expenses$39,423$34,523As reported loss from operations according to GAAP$(18,455)$(16,108)Excluding compensation expense related to equity awards(2,267)(2,732)Pro forma loss from operations$(16,188)$(13,376)Reconciliation of GAAP to Pro Forma Basis
As illustrated in the Selected Financial Information in this press release, pro forma operating expenses and pro forma loss from operations were adjusted from GAAP to exclude compensation expense related to equity awards, which are non-cash.  Isis has regularly reported non-GAAP measures for operating expenses and loss from operations as pro forma results.  These measures are provided as supplementary information and are not a substitute for financial measures calculated in accordance with GAAP.  Isis reports these pro forma results to better enable financial statement users to assess and compare its historical performance and project its future operating results and cash flows.  Further, the presentation of Isis' pro forma results is consi
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
2. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
3. Halozyme Reports First Quarter 2012 Financial Results
4. MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. IRIDEX Reports 2012 First Quarter Results
7. Cambrex Reports First Quarter 2012 Results
8. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
9. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
10. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
11. Neuland Labs Reports Financial Results For Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical ... in opioid antagonists, announced today that it has ... respect to its naloxone-based opioid overdose reversal nasal ... received an additional commitment from the National Institute ... Institutes of Health ("NIH"), to fund a second ...
(Date:7/23/2014)... 23, 2014 This September leading clinicians in ... Las Vegas for DOCtalk 2014 —a ... forward thinker and private practitioner Dr. David Sarver ... candidly discuss clinical and practice management efficiency and high ... unique opportunity to welcome fresh thinking and join a ...
(Date:7/23/2014)... LONDON , July 23, 2014 ... a business that is facing currency headwinds, increased price ... its CEO Sir Andrew Witty points out ... in the development pipeline as reason to be confident about ... to drive long-term growth. CFO Simon ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... Medical Technologies Inc. (Nasdaq: PMTI ), a ... cosmetic treatments, today announced the termination of its ... ("JJCC"), a Johnson & Johnson company, to develop, ... (i) reducing or reshaping body fat including cellulite; ...
... YORK, Oct. 16 Reportlinker.com announces that ... in its catalogue. , Reportlinker ... , http://www.reportlinker.com/p0155101/Reportlinker-Adds-Chugai-Pharmaceutical-Co-Ltd-PharmaVitae-Profile.html ... the historical and forecast performance for Chugai ...
Cached Medicine Technology:Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson 2Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson 3Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson 4Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson 5Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 2Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 3Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 4Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 5Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 6Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile 7
(Date:7/24/2014)... (PRWEB) July 24, 2014 Debt ... nonprofit credit counseling organization (DMCC), announced today that ... to help federal student loan borrowers identify and ... Education offers various repayment options to borrowers who ... options available, and the corresponding repayment terms, depend ...
(Date:7/24/2014)... and Ft. Lauderdale, FL (PRWEB) July 24, 2014 ... agreement to provide a wide range of pharmaceutical ... Under the agreement, BMG member practices can benefit ... “Blackmaple GroupPurchasing Solutions is growing rapidly, building on ... Partner. “Our approach is to offer deep savings ...
(Date:7/23/2014)... 24, 2014 The routine use ... greatly increases the likelihood of performing the correct ... cancer, report researchers from the University of Pittsburgh ... The test, available at the UPMC/UPCI Multidisciplinary Thyroid ... chances of patients getting the correct initial surgery ...
(Date:7/23/2014)... The beauty products industry is expected ... 2020, according to recent news reports. Creams and oils ... in the U.S. and the CherryNews.com company is now ... is now reviewed at http://cherrynews.com/best-nourishing-eye-serum . , This ... experienced shopper to compare the different brands offered from ...
(Date:7/23/2014)... Obtaining insurance information using offline strategies ... The Quotes Pros company is launching its finder for ... year to make research faster at http://quotespros.com/life-insurance.html . ... information are actual agencies that specialize in term, whole ... An advantage to adults who use the search platform ...
Breaking Medicine News(10 mins):Health News:Nonprofit Debt Management Credit Counseling Providing Low Cost Student Loan Help 2Health News:Nonprofit Debt Management Credit Counseling Providing Low Cost Student Loan Help 3Health News:Seacoast Medical Partners with Blackmaple Group to Provide Members Cost Savings on Wide Range of Pharmaceutical Products 2Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 2Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 3Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 4Health News:Best Wrinkle Cream Under $100 Reviewed at Top News Website Online 2Health News:Term Life Insurance Prices for All 50 States Now Explored at Insurer Website 2
... A joint announcement of the Genetics & Public ... Medicine WASHINGTON, May 5 To "get personalized ... Sebelius will need to "create and implement a ... and other advanced medical diagnostics, a diverse coalition ...
... HARBOR, N.Y. (May 5, 2009) The ... provide a supportive yet flexible framework that allows vertebrates ... knowledge about the vertebrate skeleton, especially recent research on ... a new monograph, The Skeletal System . ...
... Argus Health Systems, Inc., a leading provider of ... has been elected to the National Council for Prescription ... term. The Board of Trustees oversees all Council activities ... activities. Prior to the election, Topor, a 12-year member ...
... to Serve as Honorary Co-chair of EventBALTIMORE, May 5 ... Martha Reeves, former lead singer of the Motown group Martha ... co-chair for the organization,s fundraising walk-a-thon event. The third annual ... Independence will take place on the morning of July 6, ...
... May 5 Bates County Memorial Hospital ... has selected the MedGenix financial and patient management system. ... access, revenue cycle management and financial accounting modules. The ... Creative Healthcare Systems (CHS), based in Springfield, MO. Founded ...
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) today ... application of the Aethlon Hemopurifier(R) to treat Human ... Immune Deficiency Syndrome (AIDS). Aethlon announced that ... during the span of one month, had an ...
Cached Medicine News:Health News:Overhaul of Genetic and Other Advanced Diagnostic Testing Regulations Necessary for Personalized Medicine, HHS Secretary Told 2Health News:Overhaul of Genetic and Other Advanced Diagnostic Testing Regulations Necessary for Personalized Medicine, HHS Secretary Told 3Health News:New book summarizes current knowledge on the biology of the vertebrate skeleton 2Health News:Martha Reeves to Participate in the National Federation of the Blind Motor City March for Independence 2Health News:MedGenix Financial Information System Selected by Bates County Memorial Hospital 2Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 2Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 3Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 4Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 5
Test for prostatic acid phosphatase...
For the quantitative measurement of human prostatic acid phosphatase (PAP) in human serum....
... 2000 PC based EEG with high performance ... EEG-9200 provides high quality performance from routine ... sleep lab or EEG lab. Quality EEG ... noisy OR or ICU. Neurofax has high ...
... MagPro Compact is the first magnetic ... one-hand operated magnetic stimulation. It is designed ... help optimize the diagnostic routine (at the ... patient anxiety since you can control operations ...
Medicine Products: